MedicarePartD.guide

A non-government resource built from CMS public data

Xolair on Blue Shield Rx Enhanced (S2468-004)

omalizumab

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 8 per 28 days.

$4,546.56
Patient pays / month
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

XOLAIR PFS 75 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $13,777.46 for a month. Other covered strengths are listed below.

Prior authRequired on all 6 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 6 covered strengths and forms
FormTierPatient pays / monthLimits
XOLAIR PFS 75 mg/.5mL Injection, Solution5$4,555.83PA · 8 per 28 days
XOLAIR PFS 75 mg/.5mL Injection, Solution5$4,546.56PA · 8 per 28 days
XOLAIR PFS 150 mg/mL Injection, Solution5$4,577.91PA · 8 per 28 days
XOLAIR PFS 150 mg/mL Injection, Solution5$4,661.07PA · 8 per 28 days
XOLAIR 300 mg/2mL Injection, Solution5$4,571.73PA · 8 per 28 days
XOLAIR 300 mg/2mL Injection, Solution5$4,566.23PA · 8 per 28 days

Other Asthma and COPD biologics on this plan

Verify with the plan before prescribing or filling. Member services: (888)239-6469. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s2468-004